Skip to main content
Premium Trial:

Request an Annual Quote

San Diego Supercomputer Center Obtains New Supercomputing Cluster for Phylogenetic Research

NEW YORK, May 26 (GenomeWeb News) - A new supercomputing cluster designed for the phylogenetic research community has been installed at the San Diego Supercomputer Center, the school said earlier this week.


The cluster, which will be used to support the CyberInfrastructure for Phylogenetic Research project, is a 16-node, 8-way Fusion A8 by Western Scientific, and features 128 Opteron processors apiece with 4 gigabytes of memory.


An undisclosed grant from the National Science Foundation helped the university buy the technology, the school said.

SDSC is home to CIPRes' Central Resource, a team of biologist/programmers implementing a new generation of software tools and databases in support of the National community of Phylogenetics researchers. Researchers in the community will be able to access the new cluster through an allocation process.


CIPRes will make a formal announcement of the "policies and procedures for obtaining such an allocation" on Sept. 1, and will be posted on the CIPRes website.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.